Suppr超能文献

2010 年英国成年透析患者的生化变量:全国和中心特异性分析。

Chapter 9 Biochemical variables amongst UK adult dialysis patients in 2010: national and centre-specific analyses.

机构信息

UK Renal Registry, Bristol, UK.

出版信息

Nephron Clin Pract. 2012;120 Suppl 1:c175-210. doi: 10.1159/000342852. Epub 2012 Sep 1.

Abstract

INTRODUCTION

The UK Renal Association clinical practice guidelines include clinical performance measures for biochemical variables in dialysis patients. The UK Renal Registry (UKRR) annually audits dialysis centre performance against these measures as part of its role in promoting continuous quality improvement.

METHODS

Cross sectional performance analyses were undertaken to compare dialysis centre achievement of clinical audit measures for prevalent haemodialysis (HD) and peritoneal dialysis (PD) cohorts in 2010. The biochemical variables studied were phosphate, adjusted calcium, parathyroid hormone, bicarbonate and total cholesterol. In addition longitudinal analyses were performed (2000-2010) to show changes in achievement of clinical performance measures over time.

RESULTS

Fifty-six percent of HD and 69% of PD patients achieved a phosphate within the range recommended by the RA clinical practice guidelines. Seventy-five percent of HD and 76% of PD patients had adjusted calcium between 2.2-2.5 mmol/L. Twenty-eight percent of HD and 31% of PD patients had parathyroid hormone between 16- 32 pmol/L. Sixty percent of HD and 80% of PD patients achieved the audit measure for bicarbonate. There was significant inter-centre variation for all variables studied.

CONCLUSIONS

The UKRR consistently demonstrates significant inter-centre variation in achievement of biochemical clinical audit measures. Understanding the causes of this variation is an important part of improving the care of dialysis patients in the UK.

摘要

简介

英国肾脏协会临床实践指南包括透析患者生化变量的临床绩效指标。英国肾脏登记处(UKRR)作为其促进持续质量改进的职责的一部分,每年都会根据这些指标对透析中心的绩效进行审计。

方法

2010 年,对现患血液透析(HD)和腹膜透析(PD)患者的透析中心临床审计指标的达标情况进行了横断面绩效分析。研究的生化变量包括磷酸盐、调整后的钙、甲状旁腺激素、碳酸氢盐和总胆固醇。此外,还进行了纵向分析(2000-2010 年),以显示随着时间的推移临床绩效指标的达标情况的变化。

结果

56%的 HD 患者和 69%的 PD 患者的磷酸盐水平在 RA 临床实践指南推荐的范围内。75%的 HD 患者和 76%的 PD 患者的调整钙在 2.2-2.5mmol/L 之间。28%的 HD 患者和 31%的 PD 患者的甲状旁腺激素在 16-32pmol/L 之间。60%的 HD 患者和 80%的 PD 患者达到了碳酸氢盐的审计指标。所有研究的变量都存在显著的中心间差异。

结论

UKRR 始终表明,在生化临床审计指标的达标方面存在显著的中心间差异。了解这种差异的原因是改善英国透析患者护理的重要组成部分。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验